Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 August 2018
Alicia Puren captain of the Kovsie netball team
Alicia Puren, captain of the Kovsie netball team, will play in her fifth Varsity Netball series.

Now is the time for Kovsie Netball to claim gold again, says their captain, Alicia Puren, ahead of the Varsity Netball series.

Alicia explained that they are hungry for success, and that it’s been too long since they last won a title. “We don’t only want to win gold for our coach Burta de Kock, but also for ourselves,” said Alicia. Some of the veterans could possibly play in their final tournament, so fellow team members want them to finish on a high note.

The Kovsie Netball team won the first two competitions in 2013 and 2014, but since then could not progress further than the semi-finals. They have very favourable draws, with five of their seven matches in the group stages being played in Bloemfontein, including the game against the finalists of the previous two years, Tuks and Pukke.

They also have a very experienced team. Tanya Mostert will participate in her sixth series, Rieze Straeuli and Alicia Puren are playing in their fifth, and Khomotso Mamburu, Maryke Coetzee, Khanyisa Chawane, and Gertriana Retief are all playing in their fourth. Lefébre Rademan is playing in her third series. Jabulile Mabina, Bianca de Wee, and Petro Coetzee are the only newcomers in the squad of 15 players.

“We have a lot working in our favour; we have to make it count,” says Alicia.
Kovsie Netball will start their campaign on 26 August in the Callie Human Centre against the defending champs, Tuks.
 
Their match fixtures are as follows: 26/8 vs Tuks in Bloemfontein; 27/8 vs the University of Johannesburg in Bloemfontein; 2/9 vs the Vaal University of Technology in Bloemfontein; 3/9 vs the University of the Western Cape in Bloemfontein; 9/9 vs the Madibaz in Stellenbosch; 10/9 vs Maties in Stellenbosch, and finally 24/09 vs Pukke in Bloemfontein.

The Kovsie Netball squad players are: Alicia Puren (captain), Ané Retief, Gertriana Retief, Jana Scholtz, Khanyisa Chawane, Khomotso Mamburu, Lefébre Rademan, Meagan Roux, Sikholiwe Mdletshe, Tanya Mostert, Maryke Coetzee, Rieze Straeuli, Jabulile Mabina, Bianca de Wee, and Petro Coetzee.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept